Stockreport

Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Century Therapeutics, Inc.  (IPSC) 
PDF Announced iPSC derived beta islet cell program for Type 1 diabetes (T1D); Investigational New Drug (IND)-enabling studies expected to initiate by year-end 2025; IND subm [Read more]